Healthy ageing of cloned sheep
The health of cloned animals generated by somatic-cell nuclear transfer (SCNT) has been of concern since its inception; however, there are no detailed assessments of late-onset, non-communicable diseases. This manuscript reports that SCNT has no obvious detrimental long-term health effects in a cohort of 13 cloned sheep. Musculoskeletal assessments, metabolic tests and blood pressure measurements were carried out in 13 aged (7–9 years old) cloned sheep, including four derived from the cell line that gave rise to Dolly. The authors also performed radiological examinations of all main joints, including the knees, the joint most affected by osteoarthritis in Dolly, and compared all health parameters to groups of 5-and 6-year-old sheep, and published reference ranges. Despite their advanced age, these clones are euglycaemic, insulin sensitive and normotensive. No clinical signs of degenerative joint disease apart from mild, or in one case moderate, osteoarthritis in some animals were observed.
K.D. Sinclair et al. Nature communications 7, 2016
More news
- CRISPR off-target analysis in genetically engineered rats and mice
- The most popular genes in the human genome
- Correction of a pathogenic gene mutation in human embryos
- Easi-CRISPR
- Ethical issues of CRISPR technology and gene editing through the lens of solidarity
- Reconstitution in vitro of the entire cycle of the mouse female germ line
- Photo-activatable Cre recombinase regulates gene expression in vivo
- Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes
- High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations